Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)
Clinical trial NCT03900858 · UNKNOWN
Trial details
- NCT number
- NCT03900858
- Sponsor
- Huashan Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2022-01-01
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.